Literature DB >> 9456656

HIV-associated oral lesions: prevalence in Zambia.

T A Hodgson1.   

Abstract

OBJECTIVES: To describe the prevalence of HIV-associated oral lesions in known HIV+ subjects in Zambia and assess the predictive value of these lesions to identify individuals with CD4 cell counts less than 200 x 10(6) L-1.
SETTING: St Francis Hospital, situated in the rural Katete District, Eastern Province, Zambia.
SUBJECTS: 107 newly diagnosed heterosexual HIV positive individuals included 42% males and 58% females (mean age 34.5, range 16-62).
METHODS: Following a medical history and detailed oral examination, blood and whole saliva were collected in each subject.
RESULTS: A total of 47.7% from this sample had an AIDS diagnosis. The mean CD4 count was 252.2 cells mm-3 (s.d. +/- 160.5, range 44-810); 40.2% of the study group demonstrated oral lesions associated with HIV seropositivity. Candidiasis was most commonly seen (25% prevalence). In this population erythematous candidiasis was the only oral lesion significantly associated with CD4 counts of less than 200 x 10(6) L-1 (P < 0.05, Two-tailed Fisher's Exact Test).
CONCLUSION: In resource poor countries a thorough oral examination may suggest HIV infection and predict disease progression. Health care professional education regarding the orofacial manifestations of HIV infection needs urgent reinforcement in these areas.

Entities:  

Mesh:

Year:  1997        PMID: 9456656     DOI: 10.1111/j.1601-0825.1997.tb00373.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  8 in total

1.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

2.  Oral health status and treatment needs among HIV/AIDS patients attending antiretroviral therapy center in Western India: A cross-sectional study.

Authors:  Pankaj Chaudhary; Kanika Manral; Rahul Gupta; Aroon Kamal Singh Bengani; Bhumit Ishvarlal Chauhan; Deepanshu Arora
Journal:  J Family Med Prim Care       Date:  2020-07-30

3.  Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India.

Authors:  Gaurav Sharma; Keerthilatha M Pai; Suhas Setty; John T Ramapuram; Archna Nagpal
Journal:  Clin Oral Investig       Date:  2008-07-31       Impact factor: 3.573

4.  Oral manifestations in human immunodeficiency virus infected patients.

Authors:  Sumit Sen; Sukanta Mandal; Sourav Bhattacharya; Saswati Halder; Parna Bhaumik
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

5.  Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania.

Authors:  Omar J M Hamza; Mecky I N Matee; Elison N M Simon; Emil Kikwilu; Mainen J Moshi; Ferdinand Mugusi; Frans H M Mikx; Paul E Verweij; André J A M van der Ven
Journal:  BMC Oral Health       Date:  2006-08-18       Impact factor: 2.757

6.  Oral manifestations of human immunodeficiency virus-infected patients.

Authors:  Atessa Pakfetrat; Farnaz Falaki; Zahra Delavarian; Zohreh Dalirsani; Majid Sanatkhani; Mahsa Zabihi Marani
Journal:  Iran J Otorhinolaryngol       Date:  2015-01

7.  Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era.

Authors:  Liliane Taverne-Ghadwal; Martin Kuhns; Timo Buhl; Marco H Schulze; Weina Joseph Mbaitolum; Lydia Kersch; Michael Weig; Oliver Bader; Uwe Groß
Journal:  Front Microbiol       Date:  2022-02-17       Impact factor: 5.640

8.  Prevalence of oral lesions in hospitalized patients with infectious diseases in northern Brazil.

Authors:  Karina Gemaque; Gustavo Giacomelli Nascimento; José Luiz Cintra Junqueira; Vera Cavalcanti de Araújo; Cristiane Furuse
Journal:  ScientificWorldJournal       Date:  2014-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.